PLK3 and lung carcinoma: Data shown in Fig. 8a demonstrate that reducing the PLK3 level lowers transactivation by GOF p53 as shown by transient transcriptional assays using H1299 lung cancer cells and different promoter-luciferase constructs whose promoter activities were inhibitied by PLK3 siRNA (Fig. 8a).